Successful implementation of ClinSpark® at Phase I unit of a Top-10 Biopharmaceutical company

ClinSpark® is the eSource platform for Phase I trial automation from Foundry Health and was chosen to replace the legacy solution.This makes ClinSpark® an integral part of an ambitious innovation agenda in early clinical development.

Following the successful implementation of ClinSpark® at the Phase I unit of a top-10 biopharmaceutical company in Europe, the first study database was locked where the entire trial was conducted within the system. FDA submission-ready eCRFs of all subjects were generated in seconds and SAS data-sets from ClinSpark® are now being used to generate tables, figures and listings for the final report.

ClinSpark® is the eSource platform for Phase I trial automation from Foundry Health and was chosen to replace the legacy solution. For several months now, all new studies that start at the Phase I unit are being run in ClinSpark®. This makes ClinSpark® an integral part of an ambitious innovation agenda in early clinical development.

For a Phase I unit that is focused on first medical st-in-man studies and early clinical development, real-time access to high quality data is crucial for theaff to ensure the safety of volunteers during the study. These trials are typically complex, highly scientific in nature, always under tight deadlines and change is the only constant. ClinSpark®, an eSource system specific to the needs of a Phase I environment and early phase trials, is ideally suited to fulfill this need.

ClinSpark® is a modern, sophisticated product designed to be infinitely scalable by harnessing the power of the Cloud while being built for device and systems connectivity all while having a mobile-first computing approach. Many existing solutions are hindered by old technology, poor performance, lack of flexibility and an overall poor user experience. When the Phase I staff of this company was looking for a new solution, they realized the potential of ClinSpark®. Over the last year and a half, teams from both sides have worked closely together to ensure that ClinSpark® would meet the requirements. With version 1.4 of ClinSpark® released at the beginning of this year, that goal was achieved.

Brock Heinz, CEO of Foundry Health stated: "It was a real pleasure working with their very professional team. And while the challenges of product quality, software validation and the breadth of required functionality of one of the largest pharmaceutical companies in the world are significant, we are very happy and also proud that we've been able to meet, and at points exceed, the needs and expectations."

When the collaboration started, the list of functional gaps was not insignificant and demanded sustained effort from the Foundry Health engineers. The agile development methodology used to develop ClinSpark® typically starts with the question: "Don't tell us what you want, tell us what problem you need us to solve." From that starting point, Foundry Health engineers develop working prototypes rapidly and within several iterations back and forth with the client, new functionality is released that meets and often exceeds expectations. Using this approach, Foundry Health has made significant improvements throughout ClinSpark®, including subject recruitment and subject eligibility, the ECG review process and sample tracking and processing.

For example, based on real-life examples of complex biomarker assessments, the sample tracking features now supports the most complex of processing methods available. The application approaches electronic-lab-notebook-like functionality, available right from within ClinSpark®. This greatly enhances the capabilities of using complex biomarkers in early clinical trials. 

Brock Heinz stated: "At the end of the day, it is the user that determines success. We are so pleased to see so much positive feedback and enthusiasm coming back from this client, who now uses ClinSpark® on a daily basis."

Based on this success, the collaboration continues and keeps expanding. New developments are underway leveraging the unique connectivity abilities of ClinSpark® to efficiently enhance data collection during early clinical development to save on time and resources during later stage development.

About Foundry Health

Foundry Health is the company behind ClinSpark®, the modern cloud-based eSource platform for Phase I automation. Its modern infrastructure allows for easy connection to clinical devices, labs, databases and data review tools of all sorts. The CDISC ODM certified data structures ensure compliance with all regulatory and data standards. The modern 'mobile-first' user interface and fast bar-code enhanced navigation, make the system easy to use and contribute to the highest user experience ratings in the industry. ClinSpark® is offered as a SaaS (Software as a Service) solution with no long-term commitments, and a competitive 'pay-per-use' pricing structure. Being hosted on one of the world's most advanced cloud-infrastructures, ClinSpark® allows for almost infinite global scaling, without performance degradation.

Tags : #clinspark #biopharmaceutical #top10 #research #healthcare #technology #innovation

Related Stories

26 Feb

Did the Government Force Covid Vaccines Without Responsibility? The Supreme Court Thinks So

Will the government take responsibility, or will affected families be left fighting a lonely legal battle? The coming weeks will determine the course of justice for those who lost loved ones in the fight against COVID-19.

View
19 Dec

Why Your Blood Pressure Reading Might Be a Lie and How to Fix It

By breaking the cycle of ignorance and inaccuracy, we can turn the tide against hypertension, ensuring healthier lives for generations to come.

View
12 Dec

Plastic Pollution Goes Personal: Microplastics Found in Human Blood

This study serves as both a warning and an opportunity, a chance to rethink our relationship with plastic and prioritize the health of our planet and ourselves.

View
14 Nov

Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better Health

By embracing simple, consistent movements, each one of us has the power to boost our health, reduce our risk of disease, and live a longer, happier life.

View
09 Nov

The Deadly 17: WHO’s Vaccine Priority List to Tackle Life-Threatening Infections

By focusing on these 17 high-priority pathogens, WHO is leading the way for a world that is better prepared, more resilient, and healthier for all.

View
10 Oct

DKMS BMST Foundation India Expands Stem Cell Donor Registry with 400+ New Donors registered from IIT Delhi

DKMS BMST Foundation India, a non-profit organization dedicated to the fight against blood cancer and disorders collaborated with IIT Delhi’s cultural festival Rendezvous 2024 as the social initiative partner, driving an impactful stem cell donor registration campaign that garnered an overwhelming participation, with over 400 students registering as potential stem cell donors.

View
08 Oct

Microplastics in Bloodstream: The Hidden Link to Cardiovascular and Neurological Disorders

The emerging link between Microplastics in the Bloodstream and their potential role in triggering Cardiovascular and Neurological disorders

View
03 Oct

A New Hope for Type 1 Diabetes: Tackling Blood Sugar Drops with Somatostatin Blockers

While it may take time for this new treatment to become widely available, the potential impact on the lives of those with type 1 diabetes is enormous.

View
26 Sep

What Every Parent Needs to Know About Autism and Pandemic Babies

Contrary to earlier fears, the study found no connection between pandemic-related stress or maternal COVID-19 infection and a rise in autism rates among babies born during the pandemic.

View
05 Aug

Lingering Shadows: The Unseen Battle with Long COVID

The study highlights the urgent need for continued research and development of effective treatments to alleviate the burden of long COVID on individuals and society.

View

-Advertisements-




Trending Now

1.5 Million Bottles Recalled: Is Your ADHD Medication Safe?March 03, 2025
Dressed for Trust: Why Doctors Must Wear White Aprons AgainMarch 03, 2025
India’s Pharma Revolution: Can New Regulatory Reforms Unleash a $42 Billion Industry?March 01, 2025
Pregnant and Pained: Is Paracetamol Poisoning Our Unborn Children?March 01, 2025
Are Your Idlis Poisoning You? The Hidden Dangers of Plastic in Indian KitchensMarch 01, 2025
Stuck in Slow Motion: How Bureaucracy is Choking India’s Pharma DreamFebruary 27, 2025
A New Spine, A New Life: Inside Kerala’s First 3D-Printed Titanium Cage SurgeryFebruary 27, 2025
India’s Newborns Are Dying from Sepsis And No One Is Talking About ItFebruary 27, 2025
Did the Government Force Covid Vaccines Without Responsibility? The Supreme Court Thinks SoFebruary 26, 2025
The Inequality of Survival: Why Some Women Die While Others LiveFebruary 26, 2025
The Corporate Invasion of Indian Hospitals: What It Means for YouFebruary 26, 2025
5 Simple Daily Habits to Keep Your Joints Healthy and Pain-FreeFebruary 25, 2025
Venus Remedies Secures Exclusive In-Licensing Rights from Infex Therapeutics to Develop and Commercialize MET-X in IndiaFebruary 25, 2025
With only 70 months left to end AIDS why is the urgency missing?February 25, 2025
Drenched in Oil: Is India Cooking Its Way to an Obesity Epidemic?February 25, 2025
Transforming Education: How Online Learning Platforms are Reshaping Study Material for Board and Competitive ExamsFebruary 24, 2025
February 24, 2025
The Dark Side of India’s Pharma Boom: How Banned Drugs Found a New Market in West AfricaFebruary 24, 2025
The Great Indian Medical Education Paradox: More Seats, Fewer Students, Collapsing SystemFebruary 24, 2025
From Science Fiction to Reality: AI Now Detects Blindness Before It StartsFebruary 24, 2025